Dieter Hoffmann

Summary

Affiliation: Klinikum rechts der Isar
Country: Germany

Publications

  1. ncbi Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients
    Dieter Hoffmann
    Institute of Virology, Technische Universitat Munchen, Munich, Germany
    Infect Genet Evol 12:461-6. 2012
  2. ncbi Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletes
    Dieter Hoffmann
    Institute of Virology, Technische Universitat Munchen, Munich, Germany
    J Med Virol 82:446-51. 2010
  3. ncbi Isolated norovirus GII.7 strain within an extended GII.4 outbreak
    Dieter Hoffmann
    Institute of Virology, Technische Universitat Munchen, Munich, Germany
    J Med Virol 82:1058-64. 2010
  4. ncbi Measuring enzymatic HIV-1 susceptibility to two reverse transcriptase inhibitors as a rapid and simple approach to HIV-1 drug-resistance testing
    Dieter Hoffmann
    Laboratory Branch, Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e22019. 2011
  5. ncbi Longitudinal changes in HIV-1-specific T-cell quality associated with viral load dynamic
    Claudia J Dembek
    Institute of Virology, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, 85764 Neuherberg, Germany
    J Clin Virol 55:114-20. 2012
  6. ncbi Therapeutic vaccination reduces HIV sequence variability
    Dieter Hoffmann
    Institute of Virology, Technical University of Munich, Munich, Germany
    FASEB J 22:437-44. 2008

Detail Information

Publications6

  1. ncbi Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients
    Dieter Hoffmann
    Institute of Virology, Technische Universitat Munchen, Munich, Germany
    Infect Genet Evol 12:461-6. 2012
    ..4 epidemic strains. Evolution in a given, chronically infected individual may thus generate novel genotypes at risk to expedite global evolution particularly for slowly evolving genotypes, as GII.7...
  2. ncbi Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletes
    Dieter Hoffmann
    Institute of Virology, Technische Universitat Munchen, Munich, Germany
    J Med Virol 82:446-51. 2010
    ..These findings demonstrate that EBV is present at higher levels in athletes, but the antibody response is lower in athletes than in the controls. J. Med. Virol. 82:446-451, 2010. (c) 2010 Wiley-Liss, Inc...
  3. ncbi Isolated norovirus GII.7 strain within an extended GII.4 outbreak
    Dieter Hoffmann
    Institute of Virology, Technische Universitat Munchen, Munich, Germany
    J Med Virol 82:1058-64. 2010
    ..The results provide an insight into norovirus evolution at a University hospital over 3 years and describe intraindividual evolution within a patient infected chronically...
  4. ncbi Measuring enzymatic HIV-1 susceptibility to two reverse transcriptase inhibitors as a rapid and simple approach to HIV-1 drug-resistance testing
    Dieter Hoffmann
    Laboratory Branch, Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e22019. 2011
    ..This enzymatic testing is subtype-independent and can assist in the clinical management of diverse populations particularly in resource-limited settings...
  5. ncbi Longitudinal changes in HIV-1-specific T-cell quality associated with viral load dynamic
    Claudia J Dembek
    Institute of Virology, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, 85764 Neuherberg, Germany
    J Clin Virol 55:114-20. 2012
    ..Several correlates of HIV control have been described; however their predictive values remain unclear, since most studies have been performed in cross-sectional settings...
  6. ncbi Therapeutic vaccination reduces HIV sequence variability
    Dieter Hoffmann
    Institute of Virology, Technical University of Munich, Munich, Germany
    FASEB J 22:437-44. 2008
    ..To our knowledge this is the first report directly linking therapeutic HIV vaccination to decreasing diversity in patient-derived virus isolates...